These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 18724168)

  • 21. Fabry disease: detection of 13-bp deletion in alpha-galactosidase A gene and its application to gene diagnosis of heterozygotes.
    Ishii S; Sakuraba H; Shimmoto M; Minamikawa-Tachino R; Suzuki T; Suzuki Y
    Ann Neurol; 1991 May; 29(5):560-4. PubMed ID: 1650161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Manifestation of Fabry disease in a heterozygous female patient. New perspectives using enzyme replacement therapy].
    Jansen T; Brokalaki E; Hillen U; Hentschke M; Grabbe S
    Dtsch Med Wochenschr; 2006 Jul; 131(28-29):1590-3. PubMed ID: 16823707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oligosymptomatic cornea verticillata in a heterozygote for Fabry disease: a novel mutation in the alpha-galactosidase gene.
    Kono JO; Podskarbi T; Shin Y; Lanzl I
    Cornea; 2003 Mar; 22(2):175-7. PubMed ID: 12605057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular analysis in Fabry disease in Spain: fifteen novel GLA mutations and identification of a homozygous female.
    Rodríguez-Marí A; Coll MJ; Chabás A
    Hum Mutat; 2003 Sep; 22(3):258. PubMed ID: 12938095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fabry disease: data from four families].
    Slee PH; van Boven LJ; Slee DS
    Ned Tijdschr Geneeskd; 2000 Dec; 144(50):2412-5. PubMed ID: 11145098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fabry's disease and cornea verticillata].
    Tuppurainen K; Collan Y; Korhonen K; Rantanen T; Hollmén A
    Duodecim; 1982; 98(14):1073-8. PubMed ID: 6813100
    [No Abstract]   [Full Text] [Related]  

  • 27. Megadolichobasilar anomaly with thrombosis in a family with Fabry's disease and a novel mutation in the alpha-galactosidase A gene.
    Garzuly F; Maródi L; Erdös M; Grubits J; Varga Z; Gelpi E; Rohonyi B; Mázló M; Molnár A; Budka H
    Brain; 2005 Sep; 128(Pt 9):2078-83. PubMed ID: 15947062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and genetic analysis of Fabry disease: report of six cases including three heterozygous females.
    Nagasaki A; Nishie W; Sato K; Oba I; Noguchi E; Akitsu H; Sawamura D; Shimizu H
    J Dermatol Sci; 2008 Oct; 52(1):61-4. PubMed ID: 18555667
    [No Abstract]   [Full Text] [Related]  

  • 29. [Genetic and clinical study of three Chinese pedigrees with Fabry disease].
    Tian ML; Yan YL; Xiong JC; Liu XX; Yang Y; Hu ZX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Apr; 30(2):185-8. PubMed ID: 23568732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Biochemical study of unusual cases of Fabry disease].
    Beĭer EM; Karpova EA; Udalova OV; Tsvetkova IV
    Vopr Med Khim; 1998; 44(5):494-500. PubMed ID: 9916266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A nonsense mutation (R220X) in the alpha-galactosidase A gene causes typical Fabry disease in both genders.
    Maki N; Komatsuda A; Wakui H; Oyama Y; Kodama T; Ohtani H; Kigawa A; Aiba N; Imai H; Motegi M; Yamaguchi A; Sawada K
    Clin Nephrol; 2004 Mar; 61(3):185-90. PubMed ID: 15077869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Fabry's disease in ophthalmology (author's transl)].
    Dufier JL; Gubler MC; Dhermy P; Lenoir G; Paupe J; Haye C
    J Fr Ophtalmol; 1980; 3(11):625-30. PubMed ID: 6259247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two novel mutations in the alpha-galactosidase gene in Japanese classical hemizygotes with Fabry disease.
    Okumiya T; Takenaka T; Ishii S; Kase R; Kamei S; Sakuraba H
    Jpn J Hum Genet; 1996 Sep; 41(3):313-21. PubMed ID: 8996967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Galactose stabilizes various missense mutants of alpha-galactosidase in Fabry disease.
    Okumiya T; Ishii S; Takenaka T; Kase R; Kamei S; Sakuraba H; Suzuki Y
    Biochem Biophys Res Commun; 1995 Sep; 214(3):1219-24. PubMed ID: 7575533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anderson-Fabry disease with cerebrovascular complications in two Italian families.
    Borsini W; Giuliacci G; Torricelli F; Pelo E; Martinelli F; Scordo MR
    Neurol Sci; 2002 Jun; 23(2):49-53. PubMed ID: 12235491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical spectrum of Anderson Fabry disease in a Romanian family.
    Tudor A; Muşat A; Doscan A; Bari M; Zapucioiu C; Urdea E; Cochior D; Peţa D
    Rom J Intern Med; 2006; 44(2):201-10. PubMed ID: 17236300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a novel mutation in the alpha-galactosidase A gene in patients with Fabry disease.
    Colomba P; Nucera A; Zizzo C; Albeggiani G; Francofonte D; Iemolo F; Tuttolomondo A; Pinto A; Duro G
    Clin Biochem; 2012 Jul; 45(10-11):839-41. PubMed ID: 22465271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fabry disease--a provocation for pediatrics].
    Hoffmann B; Mayatepek E
    Klin Padiatr; 2006; 218(1):38-40. PubMed ID: 16432775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fabry disease: D313Y is an alpha-galactosidase A sequence variant that causes pseudodeficient activity in plasma.
    Froissart R; Guffon N; Vanier MT; Desnick RJ; Maire I
    Mol Genet Metab; 2003 Nov; 80(3):307-14. PubMed ID: 14680977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p.R301X Mutation and Variable Phenotypic Appearance of Fabry Disease.
    Ozelsancak R; Uyar B
    Am J Case Rep; 2016 May; 17():315-9. PubMed ID: 27156739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.